[go: up one dir, main page]

CN105663035A - Lidocaine hydrochloride injection and preparation method thereof - Google Patents

Lidocaine hydrochloride injection and preparation method thereof Download PDF

Info

Publication number
CN105663035A
CN105663035A CN201410658485.3A CN201410658485A CN105663035A CN 105663035 A CN105663035 A CN 105663035A CN 201410658485 A CN201410658485 A CN 201410658485A CN 105663035 A CN105663035 A CN 105663035A
Authority
CN
China
Prior art keywords
lidocaine hydrochloride
minutes
injection
add
stir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410658485.3A
Other languages
Chinese (zh)
Inventor
王燕
周建伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Zhaohui Pharmaceutical Co Ltd
Original Assignee
Shanghai Zhaohui Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Zhaohui Pharmaceutical Co Ltd filed Critical Shanghai Zhaohui Pharmaceutical Co Ltd
Priority to CN201410658485.3A priority Critical patent/CN105663035A/en
Publication of CN105663035A publication Critical patent/CN105663035A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供了一种盐酸利多卡因注射液,由下列重量配比的成分组成:每1000ml:盐酸利多卡因20g(理论量,所述盐酸利多卡因量需按含量、水分折干折纯投料)、氯化钠4.4~5.3g。本发明提供改进的盐酸利多卡因注射液及其制备方法,该配方组成简单,涉及辅料品种少,不仅根除了产品因没有等渗而导致的临床风险,同时使产品pH、有关物质等各项指标稳定可控、均达到2015年版药典盐酸利多卡因注射液征求意见稿要求,有利于临床使用,确保产品的安全有效。本发明方法简单,不增加新的成本,宜于规模化工业生产,有较大的应用价值。The invention provides a lidocaine hydrochloride injection, which is composed of the following components by weight ratio: per 1000ml: 20g of lidocaine hydrochloride (theoretical amount, the amount of lidocaine hydrochloride needs to be calculated according to the content, moisture content and dryness). Feeding), sodium chloride 4.4 ~ 5.3g. The invention provides an improved lidocaine hydrochloride injection and a preparation method thereof. The formula is simple in composition and involves few types of excipients, which not only eradicates the clinical risk caused by the lack of isotonicity of the product, but also makes the pH of the product, related substances, etc. The indicators are stable and controllable, and all meet the requirements of the 2015 Pharmacopoeia Lidocaine Hydrochloride Injection Draft, which is conducive to clinical use and ensures the safety and effectiveness of the product. The method of the invention is simple, does not increase new costs, is suitable for large-scale industrial production, and has great application value.

Description

一种盐酸利多卡因注射液及其制备方法A kind of lidocaine hydrochloride injection and preparation method thereof

技术领域technical field

本发明涉及药物制剂,具体涉及药物制备方法,尤其涉及盐酸利多卡因注射剂及其制备方法。The invention relates to a pharmaceutical preparation, in particular to a preparation method of the medicine, in particular to a lidocaine hydrochloride injection and a preparation method thereof.

背景技术Background technique

盐酸利多卡因注射液的主要成分为盐酸利多卡因,用于本品为局麻药及抗心律失常药。主要用于浸润麻醉、硬膜外麻醉、表面麻醉(包括在胸腔镜检查或腹腔手术时作黏膜麻醉用)及神经传导阻滞。本品也可用于急性心肌梗死后室性早搏和室性心动过速,亦可用于洋地黄类中毒、心脏外科手术及心导管引起的室性心律失常。但对于室上性心律失常通常无效。The main component of Lidocaine Hydrochloride Injection is Lidocaine Hydrochloride, which is used in this product as a local anesthetic and an antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, topical anesthesia (including mucosal anesthesia during thoracoscopic examination or abdominal surgery) and nerve conduction block. This product can also be used for premature ventricular contractions and ventricular tachycardia after acute myocardial infarction, and for ventricular arrhythmias caused by digitalis poisoning, cardiac surgery and cardiac catheterization. But it is usually ineffective for supraventricular arrhythmias.

盐酸利多卡因注射液适应症为局麻药及抗心律失常,是目前临床最常用的局麻药物,主要用于浸润麻醉、硬膜外麻醉、表面麻醉(包括在胸腔镜检查或腹腔手术时作黏膜麻醉用)及神经传导阻滞。本品也可用于急性心肌梗死后室性早搏和室性心动过速,亦可用于洋地黄类中毒、心脏外科手术及心导管引起的室性心律失常。然而,由于临床上盐酸利多卡因注射液常被用于硬膜外阻滞及骶管阻滞,该给药途径对人体的风险性大,如药液不等渗,则会增加临床用药风险,严重的甚至可能导致患者不可恢复的损伤乃至死亡。但盐酸利多卡因注射液现行版中国药典标准未对药物的渗透压进行要求,无法避免因产品不等渗带来的风险。同时,现行版中国药典中盐酸利多卡因注射液的pH标准为pH3.5~5.5,但较低的pH值往往使用药患者在用药过程中产生刺激感,且较低pH值条件下盐酸利多卡因注射液的麻醉效果不明显,因此在临床使用前医务人员往往会将盐酸利多卡因注射液pH调节为5.0~7.0(临床研究表明盐酸利多卡因注射液的麻醉效果随pH升高而提升,在pH5.0~7.0最佳)。也有文献表明pH大于6.0之后,溶液稳定性相对变差,有微粒析出,因此需要临用临配,但是这个过程由于缺乏必要的检测手段及受人员素质的影响,可能会很大程度上增加临床用药的风险。The indications for lidocaine hydrochloride injection are local anesthetics and antiarrhythmics. It is currently the most commonly used local anesthetic in clinical practice. mucosal anesthesia) and nerve conduction blockade. This product can also be used for premature ventricular contractions and ventricular tachycardia after acute myocardial infarction, and for ventricular arrhythmias caused by digitalis poisoning, cardiac surgery and cardiac catheterization. However, since lidocaine hydrochloride injection is often used clinically for epidural block and caudal block, this route of administration has a high risk to the human body. If the drug solution is not isotonic, it will increase the risk of clinical medication , Serious cases may even lead to irreversible damage or even death of the patient. However, the current version of the Chinese Pharmacopoeia standard for lidocaine hydrochloride injection does not require the osmotic pressure of the drug, and the risk caused by the non-isotonicity of the product cannot be avoided. At the same time, the pH standard of lidocaine hydrochloride injection in the current version of the Chinese Pharmacopoeia is pH 3.5 to 5.5, but lower pH values often cause irritation in patients taking the drug, and lidocaine hydrochloride injections at lower pH values The anesthesia effect of Caine Hydrochloride Injection is not obvious, so before clinical use, medical personnel often adjust the pH of Lidocaine Hydrochloride Injection to 5.0-7.0 (clinical studies have shown that the anesthetic effect of Lidocaine Hydrochloride Injection increases with the increase of pH). Enhanced, the best at pH 5.0-7.0). There are also literatures that show that when the pH is greater than 6.0, the stability of the solution is relatively poor, and particles are precipitated, so it is necessary to prepare it immediately before use. However, due to the lack of necessary detection methods and the influence of the quality of personnel, this process may greatly increase the clinical The risks of drug use.

基于盐酸利多卡因注射液的临床用药安全性以及有效性,中国2015年版药典征求意见稿中对盐酸利多卡因注射液的质量标准进行了修订,主要体现在渗透压摩尔浓度以及pH值指标,将pH值调整为pH4.0~6.0,渗透压摩尔浓度标准定为285~310mOsm/Kg。Based on the safety and effectiveness of clinical medication of lidocaine hydrochloride injection, the quality standard of lidocaine hydrochloride injection was revised in the 2015 edition of the Chinese Pharmacopoeia for comments, mainly reflected in the osmolality and pH value indicators, The pH value was adjusted to pH 4.0-6.0, and the osmolarity standard was set at 285-310 mOsm/Kg.

现有盐酸利多卡因注射液配方工艺:Existing lidocaine hydrochloride injection formulation process:

序号serial number 成分Element 1000ml理论配方量1000ml theoretical formula quantity 11 盐酸利多卡因Lidocaine Hydrochloride 20g20g 22 氯化钠Sodium chloride 8.5g8.5g 33 纯化水purified water 加至1000mlAdd to 1000ml

备注:盐酸利多卡因主药量需按含量、水分折干折纯投料。Remarks: The main drug dosage of lidocaine hydrochloride needs to be fed according to the content and moisture content.

1、配制:按配方量称取氯化钠、盐酸利多卡因,药用炭,备用。1. Preparation: Weigh sodium chloride, lidocaine hydrochloride, and medicinal charcoal according to the formula, and set aside.

2、洗烘瓶:使用超声波洗涤机对安瓿进行清洗。2. Washing and drying bottles: Use an ultrasonic washing machine to clean the ampoule.

3、配液:3. Dosing:

3.1、将70%配方量的注射用水放入配液罐中,加入配方量的氯化钠,打开搅拌机搅拌5分钟。3.1. Put 70% of the water for injection in the formula into the liquid mixing tank, add the sodium chloride in the formula, turn on the mixer and stir for 5 minutes.

3.2、将配方量的盐酸利多卡因加入配液罐内,搅拌5分钟。3.2. Add the prescribed amount of lidocaine hydrochloride into the liquid mixing tank and stir for 5 minutes.

3.3、加入配方量药用炭,搅拌5分钟。3.3. Add the formula amount of medicinal charcoal and stir for 5 minutes.

3.4、加入注射用水,打开搅拌机搅拌5分钟。3.4. Add water for injection, turn on the mixer and stir for 5 minutes.

3.5、溶液用钛滤器循环过滤10分钟。3.5. The solution was circulated and filtered with a titanium filter for 10 minutes.

3.6、溶液用钛滤器、0.45μm微孔膜筒式过滤器和0.2μm微孔膜筒式过滤器循环过滤15分钟。3.6. The solution is circulated and filtered with a titanium filter, a 0.45 μm microporous membrane cartridge filter and a 0.2 μm microporous membrane cartridge filter for 15 minutes.

3.7、调节pH值为4.0~5.0。3.7. Adjust the pH value to 4.0-5.0.

4、灌封:调节装量,在A级层流罩下进行灌封。4. Potting and sealing: adjust the filling volume, and carry out filling and sealing under the A-level laminar flow hood.

5、灭菌:在116℃灭菌30分钟。5. Sterilization: Sterilize at 116°C for 30 minutes.

6、灯检:使用人工灯检或自动灯检机进行灯检。6. Light inspection: use artificial light inspection or automatic light inspection machine for light inspection.

7、印字包装、入库。7. Printing, packaging and storage.

而如在现有盐酸利多卡因注射液配方及工艺条件下,其渗透压为415mOsm/Kg左右,远大于285mOsm/Kg~310mOsm/Kg的等渗要求。However, under the existing formula and process conditions of lidocaine hydrochloride injection, its osmotic pressure is about 415mOsm/Kg, which is far greater than the isotonic requirement of 285mOsm/Kg-310mOsm/Kg.

发明内容Contents of the invention

本发明所要解决的技术问题在于克服上述不足之处,研究设计渗透压摩尔浓度以及pH都在可控范围内的工艺质量稳定、更为安全有效的临床用盐酸利多卡因注射液的处方及配制方法。The technical problem to be solved by the present invention is to overcome above-mentioned deficiencies, research and design osmolarity and pH are all in the controllable process quality stable, safer and more effective clinical prescription and preparation of lidocaine hydrochloride injection method.

本发明提供了一种盐酸利多卡因注射液。The invention provides a lidocaine hydrochloride injection.

所述注射液由下列重量配比的成分组成(每1000ml):Described injection is made up of the composition (every 1000ml) of following weight ratio:

序号serial number 成分Element 1000ml理论配方量1000ml theoretical formula quantity 11 盐酸利多卡因Lidocaine Hydrochloride 20g20g 22 氯化钠Sodium chloride 4.4-5.3g4.4-5.3g 33 纯化水purified water 加至1000mlAdd to 1000ml

备注:盐酸利多卡因主药量需按含量、水分折干折纯投料。Remarks: The main drug dosage of lidocaine hydrochloride needs to be fed according to the content and moisture content.

本发明的另一目的是提供了上述盐酸利多卡因注射液的制备方法,该方法包括下列步骤:Another object of the present invention provides the preparation method of above-mentioned lidocaine hydrochloride injection, and this method comprises the following steps:

(1)、配制:称取氯化钠、盐酸利多卡因,药用炭,备用;(1), preparation: take by weighing sodium chloride, lidocaine hydrochloride, medicinal charcoal, standby;

(2)、洗烘瓶:使用超声波洗涤机对安瓿进行清洗;(2), washing and drying bottles: use an ultrasonic washing machine to clean the ampoule;

(3)、配液:(3), dosing:

(3.1)、将70%配方量的注射用水放入配液罐中,加入氯化钠,打开搅拌机搅拌5分钟;(3.1), put the water for injection of 70% formula quantity into the liquid mixing tank, add sodium chloride, turn on the mixer and stir for 5 minutes;

(3.2)、将盐酸利多卡因加入配液罐内,搅拌5分钟;(3.2), add lidocaine hydrochloride in the liquid mixing tank, stir for 5 minutes;

(3.3)、加入药用炭,搅拌5分钟;(3.3), add medicinal charcoal, stir for 5 minutes;

(3.4)、加入注射用水,打开搅拌机搅拌5分钟;(3.4), add water for injection, turn on the mixer and stir for 5 minutes;

(3.5)、溶液用钛滤器循环过滤10分钟;(3.5), the solution was circulated and filtered with a titanium filter for 10 minutes;

(3.6)、溶液用钛滤器、0.45μm微孔膜筒式过滤器和0.2μm微孔膜筒式过滤器循环过滤15分钟;(3.6), the solution is circulated and filtered for 15 minutes with a titanium filter, a 0.45 μm microporous membrane cartridge filter and a 0.2 μm microporous membrane cartridge filter;

(3.7)、调节pH值为4.0~6.0;调节渗透压为292mOsm/Kg~310mOsm/Kg;(3.7), adjust the pH value to 4.0~6.0; adjust the osmotic pressure to be 292mOsm/Kg~310mOsm/Kg;

(4)、灌封:调节装量,在A级层流罩下进行灌封;(4), potting: adjust the filling capacity, and potting is carried out under the A-level laminar flow hood;

(5)、灭菌:在116℃灭菌30分钟;(5) Sterilization: Sterilize at 116°C for 30 minutes;

(6)、灯检:使用人工灯检或自动灯检机进行灯检;(6) Light inspection: use manual light inspection or automatic light inspection machine for light inspection;

(7)、印字包装、入库。(7) Printing, packaging, and storage.

本发明步骤(3.7)调节pH值为4.0~6.0;优选调节pH值为5.0~5.5;选用氢氧化钠、氢氧化钾或醋酸钠、醋酸钾调节pH值。Step (3.7) of the present invention adjusts the pH value to 4.0-6.0; preferably adjusts the pH value to 5.0-5.5; selects sodium hydroxide, potassium hydroxide or sodium acetate, potassium acetate to adjust the pH value.

本发明步骤(3.7)调节渗透压为285mOsm/Kg~310mOsm/Kg;优选调节渗透压为292mOsm/Kg~310mOsm/Kg。Step (3.7) of the present invention adjusts the osmotic pressure to 285mOsm/Kg-310mOsm/Kg; preferably adjusts the osmotic pressure to 292mOsm/Kg-310mOsm/Kg.

本发明提供改进的盐酸利多卡因注射液及其制备方法,不仅根除了产品因没有等渗而导致的临床风险,同时使产品pH更有利于临床使用,避免了临床使用前医务人员调节pH,降低了因医务人员操作不当引发的临床不良反应,确保产品的安全有效。本发明方法简单,不增加新的成本,宜于规模化工业生产,有较大的应用价值。The invention provides an improved lidocaine hydrochloride injection and a preparation method thereof, which not only eradicates the clinical risk caused by the lack of isotonicity of the product, but also makes the pH of the product more favorable for clinical use, avoiding the need for medical personnel to adjust the pH before clinical use, It reduces the clinical adverse reactions caused by improper operation of medical personnel and ensures the safety and effectiveness of the product. The method of the invention is simple, does not increase new costs, is suitable for large-scale industrial production, and has great application value.

具体实施方式detailed description

以下实施例所用原料市售得到。The raw materials used in the following examples are commercially available.

实例1制备盐酸利多卡因注射液:Example 1 prepares lidocaine hydrochloride injection:

序号serial number 成分Element 1000ml配方量1000ml recipe volume 11 盐酸利多卡因Lidocaine Hydrochloride 21.565g21.565g 22 氯化钠Sodium chloride 4.9g4.9g 33 纯化水purified water 加至1000mlAdd to 1000ml

(1)、配制:按配方量称取氯化钠、盐酸利多卡因,药用炭,备用。(1), preparation: take by weighing sodium chloride, lidocaine hydrochloride, medicinal charcoal according to formula quantity, for subsequent use.

(2)、洗烘瓶:使用超声波洗涤机对安瓿进行清洗。(2) Washing and drying the bottle: use an ultrasonic washing machine to clean the ampoule.

(3)、配液:(3), dosing:

(3.1)、将70%配方量的注射用水放入配液罐中,加入配方量的氯化钠,打开搅拌机搅拌5分钟。(3.1), put the water for injection of 70% formula quantity into the liquid mixing tank, add the sodium chloride of formula quantity, turn on the mixer and stir for 5 minutes.

(3.2)、将配方量的盐酸利多卡因加入配液罐内,搅拌5分钟。(3.2), add the lidocaine hydrochloride of formula quantity in the liquid mixing tank, stir for 5 minutes.

(3.3)、加入配方量药用炭,搅拌5分钟。(3.3), add medicinal charcoal according to the formula, and stir for 5 minutes.

(3.4)、加入注射用水,打开搅拌机搅拌5分钟。(3.4), add water for injection, turn on the mixer and stir for 5 minutes.

(3.5)、溶液用钛滤器循环过滤10分钟。(3.5), the solution was circulated and filtered with a titanium filter for 10 minutes.

(3.6)、溶液用钛滤器、0.45μm微孔膜筒式过滤器和0.2μm微孔膜筒式过滤器循环过滤15分钟。(3.6), the solution is circulated and filtered for 15 minutes with a titanium filter, a 0.45 μm microporous membrane cartridge filter and a 0.2 μm microporous membrane cartridge filter.

(3.7)、用氢氧化钠水溶液(10%)调节pH值为5.0~5.5;调节渗透压为292mOsm/Kg~310mOsm/Kg。取样测定中间体的含量,含量控制在标示量的97.0~103.0%。(3.7), use sodium hydroxide aqueous solution (10%) to adjust the pH value to 5.0~5.5; adjust the osmotic pressure to be 292mOsm/Kg~310mOsm/Kg. Sampling is taken to determine the content of the intermediate, and the content is controlled at 97.0-103.0% of the marked amount.

(4)、灌封:调节装量,在A级层流罩下进行灌封。(4), potting: adjust the filling volume, and potting is carried out under the A-level laminar flow hood.

(5)、灭菌:在116℃灭菌30分钟。(5) Sterilization: Sterilize at 116° C. for 30 minutes.

(6)、灯检:使用人工灯检进行灯检。(6) Light inspection: Use artificial light inspection to perform light inspection.

(7)、印字包装、入库。(7) Printing, packaging, and storage.

实例2制备盐酸利多卡因注射液:Example 2 prepares lidocaine hydrochloride injection:

序号serial number 成分Element 1000ml配方量1000ml recipe volume 11 盐酸利多卡因Lidocaine Hydrochloride 21.565g21.565g 22 氯化钠Sodium chloride 4.4g4.4g 33 纯化水purified water 加至1000mlAdd to 1000ml

备注:盐酸利多卡因按含量、水分折干折纯投料。Remarks: lidocaine hydrochloride is fed according to the content and water content of the dry product.

(1)、配制:按配方量称取氯化钠、盐酸利多卡因,药用炭,备用。(1), preparation: take by weighing sodium chloride, lidocaine hydrochloride, medicinal charcoal according to formula quantity, for subsequent use.

(2)、洗烘瓶:使用超声波洗涤机对安瓿进行清洗。(2) Washing and drying the bottle: use an ultrasonic washing machine to clean the ampoule.

(3)、配液:(3), dosing:

(3.1)、将70%配方量的注射用水放入配液罐中,加入配方量的氯化钠,打开搅拌机搅拌5分钟。(3.1), put the water for injection of 70% formula quantity into the liquid mixing tank, add the sodium chloride of formula quantity, turn on the mixer and stir for 5 minutes.

(3.2)、将配方量的盐酸利多卡因加入配液罐内,搅拌5分钟。(3.2), add the lidocaine hydrochloride of formula quantity in the liquid mixing tank, stir for 5 minutes.

(3.3)、加入配方量药用炭,搅拌5分钟。(3.3), add medicinal charcoal according to the formula, and stir for 5 minutes.

(3.4)、加入注射用水,打开搅拌机搅拌5分钟。(3.4), add water for injection, turn on the mixer and stir for 5 minutes.

(3.5)、溶液用钛滤器循环过滤10分钟。(3.5), the solution was circulated and filtered with a titanium filter for 10 minutes.

(3.6)、溶液用钛滤器、0.45μm微孔膜筒式过滤器和0.2μm微孔膜筒式过滤器循环过滤15分钟。(3.6), the solution is circulated and filtered for 15 minutes with a titanium filter, a 0.45 μm microporous membrane cartridge filter and a 0.2 μm microporous membrane cartridge filter.

(3.7)、用氢氧化钠水溶液(15%)调节pH值为4.0~4.5;调节渗透压为280mOsm/Kg~290mOsm/Kg。取样测定中间体的含量,含量控制在标示量的97.0~103.0%。(3.7), use sodium hydroxide aqueous solution (15%) to adjust the pH value to 4.0~4.5; adjust the osmotic pressure to be 280mOsm/Kg~290mOsm/Kg. Sampling is taken to determine the content of the intermediate, and the content is controlled at 97.0-103.0% of the marked amount.

(4)、灌封:调节装量,在A级层流罩下进行灌封。(4), potting: adjust the filling volume, and potting is carried out under the A-level laminar flow hood.

(5)、灭菌:在116℃灭菌30分钟。(5) Sterilization: Sterilize at 116° C. for 30 minutes.

(6)、灯检:自动灯检机进行灯检。(6) Light inspection: automatic light inspection machine for light inspection.

(7)、印字包装、入库。(7) Printing, packaging, and storage.

实例3制备盐酸利多卡因注射液:Example 3 prepares lidocaine hydrochloride injection:

序号serial number 成分Element 1000ml配方量1000ml recipe volume 11 盐酸利多卡因Lidocaine Hydrochloride 21.565g21.565g 22 氯化钠Sodium chloride 5.3g5.3g 33 纯化水purified water 加至1000mlAdd to 1000ml

备注:盐酸利多卡按含量、水分折干折纯投料。Remarks: Lidoca hydrochloride is divided into dry and pure according to the content and water content.

(1)、配制:按配方量称取氯化钠、盐酸利多卡因,药用炭,备用。(1), preparation: take by weighing sodium chloride, lidocaine hydrochloride, medicinal charcoal according to formula quantity, for subsequent use.

(2)、洗烘瓶:使用超声波洗涤机对安瓿进行清洗。(2) Washing and drying the bottle: use an ultrasonic washing machine to clean the ampoule.

(3)、配液:(3), dosing:

(3.1)、将70%配方量的注射用水放入配液罐中,加入配方量的氯化钠,打开搅拌机搅拌5分钟。(3.1), put the water for injection of 70% formula quantity into the liquid mixing tank, add the sodium chloride of formula quantity, turn on the mixer and stir for 5 minutes.

(3.2)、将配方量的盐酸利多卡因加入配液罐内,搅拌5分钟。(3.2), add the lidocaine hydrochloride of formula quantity in the liquid mixing tank, stir for 5 minutes.

(3.3)、加入配方量药用炭,搅拌5分钟。(3.3), add medicinal charcoal according to the formula, and stir for 5 minutes.

(3.4)、加入注射用水,打开搅拌机搅拌5分钟。(3.4), add water for injection, turn on the mixer and stir for 5 minutes.

(3.5)、溶液用钛滤器循环过滤10分钟。(3.5), the solution was circulated and filtered with a titanium filter for 10 minutes.

(3.6)、溶液用钛滤器、0.45μm微孔膜筒式过滤器和0.2μm微孔膜筒式过滤器循环过滤15分钟。(3.6), the solution is circulated and filtered for 15 minutes with a titanium filter, a 0.45 μm microporous membrane cartridge filter and a 0.2 μm microporous membrane cartridge filter.

(3.7)、用氢氧化钾水溶液(10%)调节pH值为5.5~6.0;调节渗透压为292mOsm/Kg~310mOsm/Kg。(3.7), use potassium hydroxide aqueous solution (10%) to adjust the pH value to 5.5~6.0; adjust the osmotic pressure to be 292mOsm/Kg~310mOsm/Kg.

取样测定中间体的含量,含量控制在标示量的97.0~103.0%。Sampling is taken to determine the content of the intermediate, and the content is controlled at 97.0-103.0% of the marked amount.

(4)、灌封:调节装量,在A级层流罩下进行灌封。(4), potting: adjust the filling volume, and potting is carried out under the A-level laminar flow hood.

(5)、灭菌:在116℃灭菌30分钟。(5) Sterilization: Sterilize at 116° C. for 30 minutes.

(6)、灯检:使用自动灯检机进行灯检。(6) Light inspection: Use an automatic light inspection machine for light inspection.

(7)、印字包装、入库。(7) Printing, packaging, and storage.

对实施例1-3生产的盐酸利多卡因注射液进行各项指标考察,结果如下:The lidocaine hydrochloride injection that embodiment 1-3 produces is carried out every index investigation, and result is as follows:

结果说明,实施例1-3生产的盐酸利多卡因注射液各项指标都符合标准规定,pH、渗透压均符合临床使用要求,生产过程可控,满足规模化连续稳定生产要求。The results show that all indicators of the lidocaine hydrochloride injection produced in Examples 1-3 meet the standard requirements, pH and osmotic pressure meet the requirements for clinical use, the production process is controllable, and it meets the requirements for large-scale continuous and stable production.

对比例:以下是按现有制备工艺生产的产品,Comparative example: the following are products produced by the existing preparation process,

现有盐酸利多卡因注射液配方工艺:Existing lidocaine hydrochloride injection formulation process:

序号serial number 成分Element 1000ml理论配方量1000ml theoretical formula quantity 11 盐酸利多卡因Lidocaine Hydrochloride 20g20g 22 氯化钠Sodium chloride 8.5g8.5g 33 纯化水purified water 加至1000mlAdd to 1000ml

备注:盐酸利多卡因主药量需按含量、水分折干折纯投料。Remarks: The main drug dosage of lidocaine hydrochloride needs to be fed according to the content and moisture content.

1、配制:按配方量称取氯化钠、盐酸利多卡因,药用炭,备用。1. Preparation: Weigh sodium chloride, lidocaine hydrochloride, and medicinal charcoal according to the formula, and set aside.

2、洗烘瓶:使用超声波洗涤机对安瓿进行清洗。2. Washing and drying bottles: Use an ultrasonic washing machine to clean the ampoule.

3、配液:3. Dosing:

3.1、将70%配方量的注射用水放入配液罐中,加入配方量的氯化钠,打开搅拌机搅拌5分钟。3.1. Put 70% of the water for injection in the formula into the liquid mixing tank, add the sodium chloride in the formula, turn on the mixer and stir for 5 minutes.

3.2、将配方量的盐酸利多卡因加入配液罐内,搅拌5分钟。3.2. Add the prescribed amount of lidocaine hydrochloride into the liquid mixing tank and stir for 5 minutes.

3.3、加入配方量药用炭,搅拌5分钟。3.3. Add the formula amount of medicinal charcoal and stir for 5 minutes.

3.4、加入注射用水,打开搅拌机搅拌5分钟。3.4. Add water for injection, turn on the mixer and stir for 5 minutes.

3.5、溶液用钛滤器循环过滤10分钟。3.5. The solution was circulated and filtered with a titanium filter for 10 minutes.

3.6、溶液用钛滤器、0.45μm微孔膜筒式过滤器和0.2μm微孔膜筒式过滤器循环过滤15分钟。3.6. The solution is circulated and filtered with a titanium filter, a 0.45 μm microporous membrane cartridge filter and a 0.2 μm microporous membrane cartridge filter for 15 minutes.

3.7、调节pH值为4.0~5.0。3.7. Adjust the pH value to 4.0-5.0.

4、灌封:调节装量,在A级层流罩下进行灌封。4. Potting and sealing: adjust the filling volume, and carry out filling and sealing under the A-level laminar flow hood.

5、灭菌:在116℃灭菌30分钟。5. Sterilization: Sterilize at 116°C for 30 minutes.

6、灯检:使用人工灯检或自动灯检机进行灯检。6. Light inspection: use artificial light inspection or automatic light inspection machine for light inspection.

7、印字包装、入库。7. Printing, packaging and storage.

3批样品各项指标考察结果如下:The inspection results of various indicators of the three batches of samples are as follows:

从上表看出,三个样品pH较低,渗透压远超等渗要求,产品不能满足临床使用要求,临床用药的安全性得不到保证。It can be seen from the above table that the pH of the three samples is low, and the osmotic pressure far exceeds the requirement of isotonicity. The products cannot meet the requirements of clinical use, and the safety of clinical medication cannot be guaranteed.

实例4制备盐酸利多卡因注射液Example 4 prepares lidocaine hydrochloride injection

组成和制备同实例1Composition and preparation are with example 1

实例5制备盐酸利多卡因注射液Example 5 prepares lidocaine hydrochloride injection

组成和制备同实例2Composition and preparation are the same as example 2

实例6制备盐酸利多卡因注射液Example 6 prepares lidocaine hydrochloride injection

组成和制备同实例3Composition and preparation are with example 3

上述实施例4-6制备的盐酸利多卡因注射液均符合盐酸利多卡因注射液(中国药典2015年版二部第三次征求意见稿)(见下列)The lidocaine hydrochloride injection that above-mentioned embodiment 4-6 prepares all meets lidocaine hydrochloride injection (Chinese Pharmacopoeia 2015 edition two third drafts for comments) (see below)

盐酸利多卡因注射液质量标准Lidocaine hydrochloride injection quality standard

中国药典2015年版二部征求意见稿Chinese Pharmacopoeia 2015 Edition Part Two Discussion Draft

本品为盐酸利多卡因的灭菌水溶液,含盐酸利多卡因(C14H22N2O·HCl)应为标示量的95.0%~105.0%。This product is a sterilized aqueous solution of lidocaine hydrochloride, containing lidocaine hydrochloride (C14H22N2O·HCl) should be 95.0% to 105.0% of the labeled amount.

【性状】本品为无色的澄明液体。【Properties】This product is a colorless clear liquid.

【鉴别】(1)取本品,照盐酸利多卡因项下的鉴别(1)、(3)项试验,显相同结果。[Identification] (1) Take this product, according to the identification (1) and (3) tests under lidocaine hydrochloride item, the same result is shown.

(2)在含量测定项下记录的色谱图中,供试品溶液主峰的保留时间应与对照品溶液主峰的保留时间一致。(2) In the chromatogram recorded under the assay item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference substance solution.

【检查】pH值应为4.0~6.0(附录VIH)。【Check】The pH value should be 4.0~6.0 (Appendix VIH).

【有关物质】精密量取本品适量,用流动相定量稀释成每1ml中约含盐酸利多卡因2mg的溶液,作为供试品溶液;精密量取1ml,置于100ml量瓶中,用流动相稀释至刻度,作为对照溶液;另取2,6-二甲基苯胺对照品,精密称定,加流动相溶解并定量稀释制成每1ml中约含0.8μg的溶液,作为对照品溶液。照含量测定项下的色谱条件,检测波长为230nm,取对照溶液20μl,注入液相色谱仪,调节检测灵敏度,使主成分色谱峰的峰高约为满量程的20%;再精密量取上述三种溶液各20μl,分别注入液相色谱仪,记录色谱图至主成分峰保留时间的3.5倍,供试品溶液的色谱图中如有与2,6-二甲基苯胺保留时间一致的色谱峰,其峰面积不得大于对照品溶液主峰面积(0.04%),其他单个杂质峰面积不得大于对照溶液主峰面积0.5倍(0.5%),其他各杂质峰面积的和不得大于对照溶液主峰面积(1.0%)。[Related substances] Accurately measure an appropriate amount of this product, quantitatively dilute it into a solution containing 2mg of lidocaine hydrochloride in every 1ml with mobile phase, as the solution for the test; accurately measure 1ml, place it in a 100ml measuring bottle, and Phase diluted to the mark, as the reference solution; take another 2,6-dimethylaniline reference substance, accurately weighed, add mobile phase to dissolve and quantitatively dilute to make a solution containing about 0.8 μg per 1ml, as the reference substance solution. According to the chromatographic conditions under the content determination item, the detection wavelength is 230nm, and 20 μl of contrast solution is taken, injected into a liquid chromatograph, and the detection sensitivity is adjusted so that the peak height of the main component chromatographic peak is about 20% of the full scale; Each 20 μl of the three solutions is injected into the liquid chromatograph respectively, and the chromatogram is recorded to 3.5 times of the retention time of the main component peak. If there is a chromatogram with the same retention time as 2,6-dimethylaniline Peak, its peak area must not be greater than the reference substance solution main peak area (0.04%), other single impurity peak area must not be greater than 0.5 times (0.5%) the contrast solution main peak area, the sum of other each impurity peak area must not be greater than the contrast solution main peak area (1.0 %).

细菌内毒素取本品,依法检查(附录XIE),每1mg盐酸利多卡因中含内毒素的量应小于0.040EU。Bacterial endotoxins Take this product and check according to the law (Appendix XIE). The amount of endotoxin contained in every 1mg of lidocaine hydrochloride should be less than 0.040EU.

渗透压摩尔浓度取本品,依法检查(附录IXG),渗透压摩尔浓度应为285~310mOsm0l/Kg。Osmolality Take this product, check according to the law (Appendix IXG), the osmolality should be 285~310mOsm0l/Kg.

其他应符合注射剂项下有关的各项规定(附录IB)Others should comply with the relevant regulations under injection (Appendix IB)

【含量测定】照高效液相色谱法(附录VD)测定。【Content Determination】Determination according to high performance liquid chromatography (Appendix VD).

色谱条件与系统适应性试验用十八烷基硅烷键合硅胶为填充剂;以磷酸盐缓冲液(取1mol/L磷酸二氢钠溶液1.3ml和0.5mol/L磷酸氢二钠溶液32.5ml,置1000ml量瓶中,加水稀释至刻度,摇匀)-乙腈(50:50)用磷酸调节pH值至8.0为流动相;检测波长为254nm。理论塔板数按利多卡因峰计算应不低于2000。Chromatographic conditions and system suitability test use octadecylsilane bonded silica gel as filler; use phosphate buffer (take 1.3ml of 1mol/L sodium dihydrogen phosphate solution and 32.5ml of 0.5mol/L disodium hydrogen phosphate solution, Put it in a 1000ml measuring bottle, add water to dilute to the mark, shake well)-acetonitrile (50:50) and adjust the pH value to 8.0 with phosphoric acid as the mobile phase; the detection wavelength is 254nm. The theoretical plate number should not be less than 2000 based on the lidocaine peak.

测定法精密量取本品适量(约相当于盐酸利多卡因100mg),置50ml量瓶中,用流动相稀释至刻度,摇匀,精密量取20μl注入液相色谱仪,记录色谱图;另取利多卡因对照品约85mg,精密称定,置50ml量瓶中,加1mol/L盐酸溶液0.5ml使溶解,用流动相稀释至刻度,摇匀,同法测定。按外标法以峰面积计算,并乘以1.156,即得。Determination method Accurately measure an appropriate amount of this product (approximately equivalent to 100 mg of lidocaine hydrochloride), put it in a 50ml measuring bottle, dilute to the mark with mobile phase, shake well, accurately measure 20 μl and inject it into a liquid chromatograph, and record the chromatogram; Take about 85mg of lidocaine reference substance, weigh it accurately, put it in a 50ml measuring bottle, add 0.5ml of 1mol/L hydrochloric acid solution to dissolve, dilute to the mark with mobile phase, shake well, and measure in the same way. According to the external standard method to calculate the peak area, and multiplied by 1.156, that is.

【类别】同盐酸利多卡因。【Category】Same as lidocaine hydrochloride.

【规格】(1)2ml:20mg(2)2ml:40mg(3)3.5ml:35mg(4)5ml:50mg(5)5ml:0.1g(6)10ml:0.2g(7)20ml:0.4g[Specification] (1) 2ml: 20mg (2) 2ml: 40mg (3) 3.5ml: 35mg (4) 5ml: 50mg (5) 5ml: 0.1g (6) 10ml: 0.2g (7) 20ml: 0.4g

【贮藏】密闭保存。【Storage】Keep airtight.

上述实例4-6制备的盐酸利多卡因注射液成品的数据全检结果。The data full inspection result of the lidocaine hydrochloride injection finished product that above-mentioned example 4-6 prepares.

Claims (7)

1.一种盐酸利多卡因注射液,其特征在于,所述注射剂由下列重量配比的成分组成:1. a lidocaine hydrochloride injection, is characterized in that, described injection is made up of the composition of following weight ratio: 每1000mlper 1000ml 盐酸利多卡因20gLidocaine hydrochloride 20g 氯化钠4.4~5.3gSodium chloride 4.4~5.3g 纯化水加至1000ml;Add purified water to 1000ml; 所述盐酸利多卡因量按含量、水分折干折纯投料。The amount of lidocaine hydrochloride is calculated according to content and water content in dry form and pure feed intake. 2.一种盐酸利多卡因注射液,其特征在于,所述盐酸利多卡因注射液由下列重量配比的成分组成:2. a lidocaine hydrochloride injection, is characterized in that, described lidocaine hydrochloride injection is made up of the composition of following weight ratio: 每1000mlper 1000ml 盐酸利多卡因20gLidocaine hydrochloride 20g 氯化钠4.9gSodium chloride 4.9g 纯化水加至1000ml;Add purified water to 1000ml; 所述盐酸利多卡因量按含量、水分折干折纯投料。The amount of lidocaine hydrochloride is calculated according to content and water content in dry form and pure feed intake. 3.制备如权利要求1或2所述的一种盐酸利多卡因注射液的方法,其特征在于,该方法包括下列步骤:3. prepare the method for a kind of lidocaine hydrochloride injection as claimed in claim 1 or 2, it is characterized in that, the method may further comprise the steps: (1)、配制:称取氯化钠、盐酸利多卡因,药用炭,备用;(1), preparation: take by weighing sodium chloride, lidocaine hydrochloride, medicinal charcoal, standby; (2)、洗烘瓶:使用超声波洗涤机对安瓿进行清洗;(2), washing and drying bottles: use an ultrasonic washing machine to clean the ampoule; (3)、配液:(3), dosing: (3.1)、将70%配方量的注射用水放入配液罐中,加入氯化钠,打开搅拌机搅拌5分钟;(3.1), put the water for injection of 70% formula quantity into the liquid mixing tank, add sodium chloride, turn on the mixer and stir for 5 minutes; (3.2)、将盐酸利多卡因加入配液罐内,搅拌5分钟;(3.2), add lidocaine hydrochloride in the liquid mixing tank, stir for 5 minutes; (3.3)、加入药用炭,搅拌5分钟;(3.3), add medicinal charcoal, stir for 5 minutes; (3.4)、加入注射用水,打开搅拌机搅拌5分钟;(3.4), add water for injection, turn on the mixer and stir for 5 minutes; (3.5)、溶液用钛滤器循环过滤10分钟;(3.5), the solution was circulated and filtered with a titanium filter for 10 minutes; (3.6)、溶液用钛滤器、0.45μm微孔膜筒式过滤器和0.2μm微孔膜筒式过滤器循环过滤15分钟;(3.6), the solution is circulated and filtered for 15 minutes with a titanium filter, a 0.45 μm microporous membrane cartridge filter and a 0.2 μm microporous membrane cartridge filter; (3.7)、调节pH值为4.0~6.0;调节渗透压为292mOsm/Kg~310mOsm/Kg;(3.7), adjust the pH value to 4.0~6.0; adjust the osmotic pressure to be 292mOsm/Kg~310mOsm/Kg; (4)、灌封:调节装量,在A级层流罩下进行灌封;(4), potting: adjust the filling capacity, and potting is carried out under the A-level laminar flow hood; (5)、灭菌:在116℃灭菌30分钟;(5) Sterilization: Sterilize at 116°C for 30 minutes; (6)、灯检:使用人工灯检或自动灯检机进行灯检;(6) Light inspection: use manual light inspection or automatic light inspection machine for light inspection; (7)、印字包装、入库。(7) Printing, packaging, and storage. 4.根据权利要求3所述的方法,其特征在于,所述步骤3.7调节pH值为4.0~6.0,pH调节剂选自氢氧化钠或氢氧化钾。4. The method according to claim 3, characterized in that in step 3.7, the pH value is adjusted to 4.0-6.0, and the pH regulator is selected from sodium hydroxide or potassium hydroxide. 5.根据权利要求4所述的方法,其特征在于,所述步骤3.7调节pH值为5.0~5.5。5. The method according to claim 4, characterized in that in step 3.7, the pH value is adjusted to 5.0-5.5. 6.根据权利要求3所述的方法,其特征在于,所述步骤3.7渗透压摩尔浓度为285mOsm/Kg~310mOsm/Kg。6. The method according to claim 3, characterized in that, the osmolarity in the step 3.7 is 285mOsm/Kg-310mOsm/Kg. 7.根据权利要求6所述的方法,其特征在于,所述步骤3.7渗透压摩尔浓度为292mOsm/Kg~310mOsm/Kg。7. The method according to claim 6, characterized in that the osmolarity in step 3.7 is 292 mOsm/Kg-310 mOsm/Kg.
CN201410658485.3A 2014-11-18 2014-11-18 Lidocaine hydrochloride injection and preparation method thereof Pending CN105663035A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410658485.3A CN105663035A (en) 2014-11-18 2014-11-18 Lidocaine hydrochloride injection and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410658485.3A CN105663035A (en) 2014-11-18 2014-11-18 Lidocaine hydrochloride injection and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105663035A true CN105663035A (en) 2016-06-15

Family

ID=56944386

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410658485.3A Pending CN105663035A (en) 2014-11-18 2014-11-18 Lidocaine hydrochloride injection and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105663035A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590590A (en) * 2019-10-18 2019-12-20 海南顿斯医药科技有限公司 1A1/5Lidocaine hydrochloride hydrate compound
CN111208236A (en) * 2020-03-05 2020-05-29 遂成药业股份有限公司 Method for measuring related substances of lidocaine hydrochloride by high performance liquid chromatography
CN112375009A (en) * 2020-11-27 2021-02-19 山东华鲁制药有限公司 Production method and application of lidocaine hydrochloride
CN112933041A (en) * 2021-03-05 2021-06-11 遂成药业股份有限公司 Preparation method of lidocaine hydrochloride injection
CN114246958A (en) * 2020-09-21 2022-03-29 南京济群医药科技股份有限公司 A kind of preparation technology of plastic ampoule packaged sterilized lidocaine hydrochloride injection
WO2024210763A1 (en) * 2023-04-05 2024-10-10 Константин Павлович ГАРЯЕВ Injectable drug composition for treating atherosclerosis and method for using same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
国家药典委员会: "关于盐酸利多卡因注射液标准的公示", 《国家药典委员会征求意见稿》 *
朱建明: "碱化的利多卡因作为局麻药有效期的研究", 《冶金医药情报》 *
李晓瑞等: "活性炭在注射液配制中对主药含量的影响研究", 《亚太传统医药》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590590A (en) * 2019-10-18 2019-12-20 海南顿斯医药科技有限公司 1A1/5Lidocaine hydrochloride hydrate compound
CN111208236A (en) * 2020-03-05 2020-05-29 遂成药业股份有限公司 Method for measuring related substances of lidocaine hydrochloride by high performance liquid chromatography
CN114246958A (en) * 2020-09-21 2022-03-29 南京济群医药科技股份有限公司 A kind of preparation technology of plastic ampoule packaged sterilized lidocaine hydrochloride injection
CN112375009A (en) * 2020-11-27 2021-02-19 山东华鲁制药有限公司 Production method and application of lidocaine hydrochloride
CN112933041A (en) * 2021-03-05 2021-06-11 遂成药业股份有限公司 Preparation method of lidocaine hydrochloride injection
WO2024210763A1 (en) * 2023-04-05 2024-10-10 Константин Павлович ГАРЯЕВ Injectable drug composition for treating atherosclerosis and method for using same

Similar Documents

Publication Publication Date Title
CN105663035A (en) Lidocaine hydrochloride injection and preparation method thereof
CN102988291A (en) Flurbiprofen axetil fat emulsion injection composition and preparation method thereof
CN111481501B (en) Ketorolac tromethamine injection capable of reducing irritation and free of organic solvent
CN108992400B (en) Pharmaceutical composition containing irinotecan hydrochloride and preparation method thereof
WO2020248648A1 (en) Ornidazole injection and s-ornidazole injection
CN102670489B (en) Ropivacaine hydrochloride sodium chloride injection and preparation method thereof
CN102973499A (en) Asarone injection and preparation method thereof
CN107041868B (en) A kind of stable ornidazole injection and S- ornidazole injection and preparation method thereof
CN113521244B (en) Argatroban injection and preparation method thereof
CN102813622B (en) Ornidazole sodium chloride injection composition and preparation method thereof
CN113876697A (en) Dopamine hydrochloride injection and preparation process thereof
CN103860461A (en) Medicinal composition containing active component ambroxol hydrochloride
CN103877005A (en) Compound olanzapine subcutaneous implantable sustained-release preparation
CN101708157B (en) Isosorbide mononitrate sodium chloride injection
CN104069063B (en) Fasudic hydrochloride pharmaceutical composition and preparation method thereof
CN104414968A (en) Levofloxacin single-dose eye drops and preparation method thereof
CN104771360B (en) A kind of Artemether nanoemulsion drug combination and preparation method thereof
CN101322684A (en) Acetic acid desmopressin injection prescription and preparation technique thereof
CN103877016B (en) Pharmaceutical composition of naloxone hydrochloride injection and preparation method thereof
CN103159710B (en) Antiviral decalin derivate
CN101839902A (en) Application of intestinal absorption test in identifying potential unsafe components in Chinese medicine injection
CN112121006A (en) Vitamin ADE composition for injection livestock and preparation method thereof
CN104688674B (en) A kind of preparation method of bemegrid parenteral solution
CN103239416A (en) Injection composition with isosorbide mononitrate and preparation method for injection composition
CN117180189A (en) Shubianli injection and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160615

RJ01 Rejection of invention patent application after publication